| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $149,820,989 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS120930 | Molecular basis for adenosine A3 receptor agonists in the treatment of migraine | 000 | 3 | NIH | 11/28/2023 | $425,628 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI168192 | Mechanisms coordinating the local and systemic resistance to pathogens | 001 | 2 | NIH | 5/13/2024 | $59,607 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI168192 | Mechanisms coordinating the local and systemic resistance to pathogens | 000 | 2 | NIH | 10/24/2023 | $536,463 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R37NS125632 | KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target | 001 | 3 | NIH | 5/14/2024 | $25,393 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R37NS125632 | KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target | 000 | 3 | NIH | 12/12/2023 | $326,498 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI174952 | Decoding HIV-1 mediated Hematopathology | 001 | 2 | NIH | 5/21/2024 | $19,312 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI174952 | Decoding HIV-1 mediated Hematopathology | 000 | 2 | NIH | 1/25/2024 | $173,813 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25AI175017 | Maryland Infection, Immunization, Intervention, and Impact (M4I) Training Program | 000 | 1 | NIH | 7/9/2024 | $337,719 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25AG090804 | UMB RAMP: UMB Research And Mentoring Program to develop skills and promote interest in STEM fields through hands-on exposure to academic research among West Baltimore Youth | 000 | 1 | NIH | 6/14/2024 | $265,863 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R34AI179569 | Safety, immunogencity, and efficacy of PfSPZ LARC2 malaria vaccine in malaria-exposed adults and children | 000 | 1 | NIH | 6/12/2024 | $250,796 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI148270 | Characterization of neutralizing antitoxins and epitopes in Clostridium difficile patients | 001 | 5 | NIH | 5/20/2024 | $38,625 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH121102 | Translational assessment of brain bioenergetic function in schizophrenia | 001 | 5 | NIH | 6/3/2024 | $70,441 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH121102 | Translational assessment of brain bioenergetic function in schizophrenia | 000 | 5 | NIH | 10/30/2023 | $633,965 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI148270 | Characterization of neutralizing antitoxins and epitopes in Clostridium difficile patients | 000 | 5 | NIH | 12/14/2023 | $347,625 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS114045 | CNV And Stroke (CaNVAS) | 001 | 5 | NIH | 4/17/2024 | $35,323 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS114045 | CNV And Stroke (CaNVAS) | 000 | 5 | NIH | 11/29/2023 | $454,179 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD102206 | Autophagy and its Regulation in Diabetic Embryopathy | 001 | 9 | NIH | 5/6/2024 | $45,163 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD102206 | Autophagy and its Regulation in Diabetic Embryopathy | 000 | 9 | NIH | 2/29/2024 | $451,627 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08HL146893 | Mechanisms of aortopathy in LRP1 deficiency | 000 | 5 | NIH | 11/6/2023 | $163,188 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG065338 | Testing the Efficacy of FFC-AC-EIT in Patients with Alzheimers Disease and Related Dementias | 001 | 5 | NIH | 6/4/2024 | $44,298 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG065338 | Testing the Efficacy of FFC-AC-EIT in Patients with Alzheimers Disease and Related Dementias | 000 | 5 | NIH | 12/13/2023 | $398,690 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS107262 | Sur1-Trpm4 regulation of the pro-inflammatory astrocytic secretome in EAE | 001 | 5 | NIH | 4/10/2024 | $23,658 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS107262 | Sur1-Trpm4 regulation of the pro-inflammatory astrocytic secretome in EAE | 000 | 5 | NIH | 1/10/2024 | $304,172 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI147870 | Engineering of pan-neutralizing anti-HIV envelope antibodies | 001 | 5 | NIH | 5/15/2024 | $38,560 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI147870 | Engineering of pan-neutralizing anti-HIV envelope antibodies | 000 | 5 | NIH | 11/15/2023 | $347,035 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21NS139180 | Hyperpolarized MRI for Metabolic Imaging of Epileptic Tissue | 000 | 1 | NIH | 7/9/2024 | $427,625 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R03AI182671 | Analysis of cord blood Vd2 T cell differentiation and function using CITE-seq and ATAC-seq | 000 | 1 | NIH | 7/5/2024 | $84,757 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21EY035483 | Development of Robust Corneal Biomechanical Biomarkers for Glaucoma Using Brillouin Microscopy | 000 | 1 | NIH | 6/17/2024 | $230,430 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI180502 | Parasite variant surface antigen expression and immune gaps in severe malaria | 000 | 1 | NIH | 7/9/2024 | $226,991 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21HD115013 | CD38 intensifies immune activation in women living with HIV (the CIGNAL study) | 000 | 1 | NIH | 7/15/2024 | $193,125 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DC012564 | Usher Proteins in the Inner ear Structure and Function | 000 | 12 | NIH | 1/11/2024 | $655,160 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG081693 | Deep-Learning Enhanced ASL MRI For Early AD Assessment | 000 | 1 | NIH | 3/12/2024 | $775,807 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012274 | INSIGHT Supplement June 2024 | 001 | 3 | NIH | 7/11/2024 | $80,373 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012274 | INSIGHT Supplement June 2024 | 000 | 3 | NIH | 6/5/2024 | $515,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012274 | INSIGHT Supplement June 2024 | 000 | 3 | NIH | 6/5/2024 | $385,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012274 | INSIGHT Supplement June 2024 | 000 | 3 | NIH | 6/5/2024 | $50,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG073236 | LRP1-tau interactions and Alzheimer Disease | 000 | 2 | NIH | 7/15/2024 | $792,690 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI180125 | Isolation of broadly protective monoclonal antibodies for Crimean Congo Hemorrhagic Fever | 000 | 1 | NIH | 7/23/2024 | $685,980 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS138179 | A pericyte Cl- clamp controls capillary electrical signaling and brain blood flow | 000 | 1 | NIH | 7/23/2024 | $433,159 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | T3442149 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 00 | 4 | HRSA | 5/24/2024 | $473,993 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL166402 | Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes | 001 | 2 | NIH | 6/8/2024 | $44,794 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL166402 | Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes | 000 | 2 | NIH | 12/20/2023 | $503,935 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA271540 | Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC | 001 | 2 | NIH | 4/18/2024 | $26,026 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA271540 | Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC | 000 | 2 | NIH | 12/15/2023 | $468,472 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL168775 | Airway epithelial cytoglobin regulates nitric oxide synthase and development of primary ciliary dyskinesia and situs inversus | 001 | 1 | NIH | 6/13/2024 | $69,761 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL168775 | Airway epithelial cytoglobin regulates nitric oxide synthase and development of primary ciliary dyskinesia and situs inversus | 000 | 1 | NIH | 12/1/2023 | $655,106 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD108705 | Intersection of the mTOR/p70S6K1 signaling and the HIPPO-Yap tissue organizer in neurulation and diabetic embryopathy | 001 | 2 | NIH | 5/6/2024 | $58,665 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD108705 | Intersection of the mTOR/p70S6K1 signaling and the HIPPO-Yap tissue organizer in neurulation and diabetic embryopathy | 000 | 2 | NIH | 11/14/2023 | $586,642 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH136968 | A circuit mechanism for the interactions between distinct learning systems | 000 | 1 | NIH | 7/18/2024 | $500,228 |
|